These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 31230678)

  • 21. [Dependence on benzodiazepines. Clinical and biological aspects].
    Pelissolo A; Bisserbe JC
    Encephale; 1994; 20(2):147-57. PubMed ID: 7914165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The nitrate withdrawal syndrome. A review of the literature and the data from the authors' own research].
    Martsevich SIu; Metelitsa VI; Kutishenko NP
    Ter Arkh; 1992; 64(12):73-6. PubMed ID: 1292140
    [No Abstract]   [Full Text] [Related]  

  • 23. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.
    Nardi AE; Freire RC; Valença AM; Amrein R; de Cerqueira AC; Lopes FL; Nascimento I; Mezzasalma MA; Veras AB; Sardinha A; de Carvalho MR; da Costa RT; Levitan MN; de-Melo-Neto VL; Soares-Filho GL; Versiani M
    J Clin Psychopharmacol; 2010 Jun; 30(3):290-3. PubMed ID: 20473065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine withdrawal, treatments 1900-30.
    Malcolm MT
    Hist Psychiatry; 1999 Mar; 10(37):13-26. PubMed ID: 11623818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Controlled tapering of medication. What do structured treatment withdrawal achieve?].
    MMW Fortschr Med; 2000; 142(3 Suppl):25-6. PubMed ID: 10893958
    [No Abstract]   [Full Text] [Related]  

  • 26. Withdrawal syndrome with gradual tapering of alprazolam.
    Mellman TA; Uhde TW
    Am J Psychiatry; 1986 Nov; 143(11):1464-6. PubMed ID: 3535544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The authors reply.
    Best KM; Wypij D; Asaro LA; Curley MAQ
    Crit Care Med; 2017 Jun; 45(6):e623-e624. PubMed ID: 28509749
    [No Abstract]   [Full Text] [Related]  

  • 28. Dopamine agonist withdrawal syndrome: A comprehensive review.
    Yu XX; Fernandez HH
    J Neurol Sci; 2017 Mar; 374():53-55. PubMed ID: 28104232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of triazolam dependence with a tapering withdrawal regimen.
    Singh AN; Chemij M; Jewell J
    CMAJ; 1986 Feb; 134(3):243-5. PubMed ID: 3942931
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of a high-dose fast tapering buprenorphine detoxification program on symptom relief and treatment retention.
    Palmstierna T
    J Psychoactive Drugs; 2004 Jun; 36(2):273-7. PubMed ID: 15369209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-hydroxybutyrate detoxification by titration and tapering.
    de Jong CA; Kamal R; Dijkstra BA; de Haan HA
    Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of scheduled withdrawal from nortriptyline in children and adolescents.
    Geller B; Cooper TB; Carr LG; Warham JE; Rodriguez A
    J Clin Psychopharmacol; 1987 Aug; 7(4):252-4. PubMed ID: 3624507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
    Risse SC; Whitters A; Burke J; Chen S; Scurfield RM; Raskind MA
    J Clin Psychiatry; 1990 May; 51(5):206-9. PubMed ID: 2335496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
    Fava GA; Benasi G; Lucente M; Offidani E; Cosci F; Guidi J
    Psychother Psychosom; 2018; 87(4):195-203. PubMed ID: 30016772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.
    Fava GA; Gatti A; Belaise C; Guidi J; Offidani E
    Psychother Psychosom; 2015; 84(2):72-81. PubMed ID: 25721705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.
    Connor DF; Benjamin S; Ozbayrak KR
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1490-4. PubMed ID: 8543517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carisoprodol withdrawal syndrome.
    Reeves RR; Beddingfield JJ; Mack JE
    Pharmacotherapy; 2004 Dec; 24(12):1804-6. PubMed ID: 15585447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxcarbazepine in rapid benzodiazepine detoxification.
    Croissant B; Grosshans M; Diehl A; Mann K
    Am J Drug Alcohol Abuse; 2008; 34(5):534-40. PubMed ID: 18821451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Taperingstrips for paroxetine and venlafaxine].
    Groot PC;
    Tijdschr Psychiatr; 2013; 55(10):789-94. PubMed ID: 24194351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanism of neuroleptic withdrawal.
    Eppel AB; Mishra R
    Can J Psychiatry; 1984 Oct; 29(6):508-9. PubMed ID: 6149010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.